Other
Payment for (Proceeds from) Other Investing Activity
Vertex Pharmaceuticals Payment for (Proceeds from) Other Investing Activity decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $5.30M to $0.00. Over 3 years (FY 2022 to FY 2025), Payment for (Proceeds from) Other Investing Activity shows a downward trend with a -18.9% CAGR.
Analysis
StatementIncome Statement
SectionOther
CategoryOther
SignalContext dependent
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
How to read this metric
Large fluctuations may indicate one-time events or non-recurring financial adjustments that require further investigation.
Detailed definition
Captures miscellaneous cash flows related to investing activities that do not fit into standard categories like capital...
Peer comparison
Often used as a catch-all category in cash flow statements across various sectors.
Metric ID:
other_payments_for_proceeds_from_other_investing_activitiesHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $11.95M | $11.95M | $11.95M | $11.95M | $7.75M | $7.75M | $7.75M | $7.75M | $0.00 | $15.00M | $8.10M | $30.90M | $5.30M | $4.30M | $0.00 | $15.90M | $0.00 |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -35.1% | +0.0% | +0.0% | +0.0% | -100.0% | — | -46.0% | +281.5% | -82.8% | -18.9% | -100.0% | — | -100.0% |
| YoY Change | — | — | — | — | -35.1% | -35.1% | -35.1% | -35.1% | -100.0% | +93.5% | +4.5% | +298.7% | — | -71.3% | -100.0% | -48.5% | -100.0% |
Range$0.00 – $30.90M
CAGR-100.0%
Avg YoY Growth-13.6%
Median YoY Growth-35.1%
Current Streak5 quarters decline
Payment for (Proceeds from) Other Investing Activity at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's payment for (proceeds from) other investing activity?
- Vertex Pharmaceuticals (VRTX) reported payment for (proceeds from) other investing activity of $0.00 in Q1 2026.
- How has Vertex Pharmaceuticals's payment for (proceeds from) other investing activity changed year-over-year?
- Vertex Pharmaceuticals's payment for (proceeds from) other investing activity decreased by 100.0% year-over-year, from $5.30M to $0.00.
- What is the long-term trend for Vertex Pharmaceuticals's payment for (proceeds from) other investing activity?
- Over 3 years (2022 to 2025), Vertex Pharmaceuticals's payment for (proceeds from) other investing activity has grown at a -18.9% compound annual growth rate (CAGR), from $47.80M to $25.50M.
- What does payment for (proceeds from) other investing activity mean?
- Net cash flows from miscellaneous investing activities not classified elsewhere.